ACLX
Price
$63.34
Change
+$2.41 (+3.96%)
Updated
Apr 22, 02:12 PM (EDT)
Capitalization
3.36B
16 days until earnings call
RNA
Price
$28.52
Change
+$1.86 (+6.98%)
Updated
Apr 21 closing price
Capitalization
3.43B
21 days until earnings call
Ad is loading...

ACLX vs RNA

Header iconACLX vs RNA Comparison
Open Charts ACLX vs RNABanner chart's image
Arcellx
Price$63.34
Change+$2.41 (+3.96%)
Volume$625
Capitalization3.36B
Avidity Biosciences
Price$28.52
Change+$1.86 (+6.98%)
Volume$1.33M
Capitalization3.43B
ACLX vs RNA Comparison Chart
Loading...
ACLX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RNA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ACLX vs. RNA commentary
Apr 22, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ACLX is a Hold and RNA is a Hold.

Ad is loading...
COMPARISON
Comparison
Apr 22, 2025
Stock price -- (ACLX: $60.93 vs. RNA: $28.52)
Brand notoriety: ACLX and RNA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ACLX: 37% vs. RNA: 84%
Market capitalization -- ACLX: $3.36B vs. RNA: $3.43B
ACLX [@Biotechnology] is valued at $3.36B. RNA’s [@Biotechnology] market capitalization is $3.43B. The market cap for tickers in the [@Biotechnology] industry ranges from $285.37B to $0. The average market capitalization across the [@Biotechnology] industry is $2.08B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ACLX’s FA Score shows that 0 FA rating(s) are green whileRNA’s FA Score has 0 green FA rating(s).

  • ACLX’s FA Score: 0 green, 5 red.
  • RNA’s FA Score: 0 green, 5 red.
According to our system of comparison, RNA is a better buy in the long-term than ACLX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ACLX’s TA Score shows that 4 TA indicator(s) are bullish while RNA’s TA Score has 3 bullish TA indicator(s).

  • ACLX’s TA Score: 4 bullish, 6 bearish.
  • RNA’s TA Score: 3 bullish, 6 bearish.
According to our system of comparison, ACLX is a better buy in the short-term than RNA.

Price Growth

ACLX (@Biotechnology) experienced а +1.04% price change this week, while RNA (@Biotechnology) price change was +5.98% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.43%. For the same industry, the average monthly price growth was -12.93%, and the average quarterly price growth was -15.58%.

Reported Earning Dates

ACLX is expected to report earnings on Aug 18, 2025.

RNA is expected to report earnings on Aug 12, 2025.

Industries' Descriptions

@Biotechnology (+1.43% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
RNA($3.43B) and ACLX($3.36B) have the same market capitalization . RNA YTD gains are higher at: -1.926 vs. ACLX (-20.550). ACLX has higher annual earnings (EBITDA): -99.06M vs. RNA (-376.16M). RNA has more cash in the bank: 1.5B vs. ACLX (587M). RNA has less debt than ACLX: RNA (6.8M) vs ACLX (54.1M). ACLX has higher revenues than RNA: ACLX (108M) vs RNA (10.9M).
ACLXRNAACLX / RNA
Capitalization3.36B3.43B98%
EBITDA-99.06M-376.16M26%
Gain YTD-20.550-1.9261,067%
P/E RatioN/AN/A-
Revenue108M10.9M991%
Total Cash587M1.5B39%
Total Debt54.1M6.8M795%
TECHNICAL ANALYSIS
Technical Analysis
ACLXRNA
RSI
ODDS (%)
Bullish Trend 1 day ago
90%
N/A
Stochastic
ODDS (%)
Bearish Trend 1 day ago
73%
Bullish Trend 6 days ago
80%
Momentum
ODDS (%)
Bullish Trend 1 day ago
89%
Bearish Trend 6 days ago
86%
MACD
ODDS (%)
Bullish Trend 1 day ago
86%
Bearish Trend 6 days ago
78%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
88%
Bullish Trend 6 days ago
86%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
77%
Bearish Trend 6 days ago
85%
Advances
ODDS (%)
Bullish Trend 8 days ago
87%
Bullish Trend 9 days ago
86%
Declines
ODDS (%)
Bearish Trend 15 days ago
78%
Bearish Trend 7 days ago
85%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
80%
Bullish Trend 6 days ago
83%
Aroon
ODDS (%)
Bearish Trend 1 day ago
81%
Bearish Trend 6 days ago
86%
View a ticker or compare two or three
Ad is loading...
ACLX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RNA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
ACGGX18.11N/A
N/A
American Century Global Gold A
RAGHX25.54N/A
N/A
Virtus KAR Health Sciences A
CVFYX14.11N/A
N/A
Pioneer Disciplined Value Y
VVIAX63.11N/A
N/A
Vanguard Value Index Adm
DVLRX53.49-1.10
-2.02%
Macquarie Small Cap Value R

ACLX and

Correlation & Price change

A.I.dvisor indicates that over the last year, ACLX has been loosely correlated with RCKT. These tickers have moved in lockstep 56% of the time. This A.I.-generated data suggests there is some statistical probability that if ACLX jumps, then RCKT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ACLX
1D Price
Change %
ACLX100%
-1.76%
RCKT - ACLX
56%
Loosely correlated
+13.27%
DNLI - ACLX
55%
Loosely correlated
+3.22%
KRYS - ACLX
55%
Loosely correlated
-3.95%
ROIV - ACLX
54%
Loosely correlated
-1.08%
RNA - ACLX
52%
Loosely correlated
+6.98%
More

RNA and

Correlation & Price change

A.I.dvisor indicates that over the last year, RNA has been loosely correlated with ACLX. These tickers have moved in lockstep 52% of the time. This A.I.-generated data suggests there is some statistical probability that if RNA jumps, then ACLX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RNA
1D Price
Change %
RNA100%
+6.98%
ACLX - RNA
52%
Loosely correlated
-1.76%
STOK - RNA
48%
Loosely correlated
+11.96%
CRNX - RNA
47%
Loosely correlated
-0.89%
DYN - RNA
47%
Loosely correlated
+14.20%
ROIV - RNA
46%
Loosely correlated
-1.08%
More